This role offers the opportunity to shape the safety strategy for high-impact cell therapy assets across pre-clinical, clinical, and post-marketing stages.
Base: $288,059.20 - $432,088.80 USD; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: Qualified retirement program (401k), paid vacation/holidays, leaves, medical/dental/vision coverage
Must-have
Nice-to-have
Not specified